Company profile
Xenon Pharmaceuticals Inc. Insider Trading
XENEEvery SEC Form 4 insider trading filing for Xenon Pharmaceuticals Inc. (XENE) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001582313
- Filings
- 76
- Insiders
- 18
- Last filing
- 2026-09-01
Activity summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares (net $42K). Buying was led by Dawn Svoronos.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Xenon Pharmaceuticals Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $19.6M.
90 day insight
Over the last 90 days, Xenon Pharmaceuticals Inc. insiders bought $42K (2 transactions) and sold $641K (1 transaction).
- Most active insider: Christopher John Kenney with 2 transactions totaling $426K.
- Largest single sale: $641K by Steven Gannon on Aug 11, 2026.
- 67% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Dawn Svoronos | XENE | Option Exercise | 5,144 | $8.15 | $42K |
| Sep 1, 2026 | Dawn Svoronos | XENE | Option Exercise | 5,144 | — | — |
| Aug 28, 2026 | Christopher John Kenney | XENE | Sale10b5 | 6,368 | $60.17 | $383K |
| Aug 28, 2026 | Christopher John Kenney | XENE | Sale10b5 | 700 | $60.98 | $43K |
| Aug 11, 2026 | Steven Gannon | XENE | Sale | 10,000 | $64.06 | $641K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=XENE" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Xenon Pharmaceuticals Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →